What is the recommended management for sudden sensorineural hearing loss?

Management of Sudden Sensorineural Hearing Loss

Offer systemic corticosteroids as initial therapy within 2 weeks of symptom onset, and if recovery is incomplete at 2-6 weeks, provide intratympanic steroid salvage therapy. 1

Initial Diagnostic Approach

Confirm the diagnosis with audiometry within 14 days of symptom onset to document at least 30 dB hearing loss over three contiguous frequencies. 1 Do not delay treatment waiting for audiometry if clinical suspicion is high, but formal testing is essential for confirming SSNHL versus conductive hearing loss. 1

Key History and Physical Examination Elements

Assess specifically for: 1

• Bilateral hearing loss (suggests systemic disease requiring different workup)
• Recurrent episodes (points toward autoimmune or Meniere's disease)
• Focal neurologic findings (cranial nerve deficits, ataxia, weakness)
• Associated vertigo (indicates poorer prognosis) 1
• Tinnitus and aural fullness (common accompanying symptoms) 1

What NOT to Order

Avoid routine laboratory testing - there is no evidence supporting nontargeted labs in idiopathic SSNHL. 1

Avoid routine head CT - this does not aid diagnosis and delays appropriate management. 1 Targeted temporal bone CT may be appropriate if conductive pathology is suspected, but this is a different scenario. 1

Do not prescribe antivirals, thrombolytics, vasodilators, or vasoactive substances - these have no proven benefit and represent unnecessary treatment. 1

Treatment Algorithm Based on Timing

Within 2 Weeks of Symptom Onset (Initial Therapy)

First-line: Systemic corticosteroids 1

• Prednisone 1 mg/kg/day (maximum 60 mg/day) for 7-14 days, then taper over similar period 1
• Alternative: Methylprednisolone 48 mg/day or Dexamethasone 10 mg/day 1
• Evidence is mixed regarding efficacy versus placebo, but the risk-benefit ratio favors treatment given low harm potential and possible significant benefit 1, 2

Alternative if systemic steroids contraindicated: Intratympanic steroids can be used as initial therapy with non-inferior efficacy 1

• Dexamethasone 24 mg/mL (compounded) or 10 mg/mL (stock) 1
• Inject 0.4-0.8 mL into middle ear space 1
• Keep head in otologic position (affected ear up) for 15-30 minutes 1

Optional adjunct: Hyperbaric oxygen therapy (HBOT) combined with steroids within 2 weeks of onset 1 This is an option, not a recommendation, and requires specialized facilities. 1

At 2-6 Weeks: Salvage Therapy for Incomplete Recovery

Intratympanic steroid therapy should be offered when initial treatment fails to achieve complete recovery. 1 This is a recommendation, not merely an option. 1

• Up to 4 injections over a 2-week period 1
• Interval audiograms between injections may guide early termination if hearing recovers 1
• Consider pressure-equalizing tube if planning multiple injections, though this increases perforation risk 1

Optional: HBOT combined with steroids can be offered as salvage therapy within 1 month of onset. 1

Essential Workup for Retrocochlear Pathology

Obtain MRI with gadolinium or auditory brainstem response (ABR) to rule out vestibular schwannoma and other retrocochlear lesions. 1, 2

• MRI is the most sensitive test 1
• ABR is less sensitive but acceptable if MRI is contraindicated or unavailable 1
• If ABR is abnormal, MRI must follow 1
• Timing is not specified in guidelines, but this should not delay initial steroid treatment 1

Patient Counseling (Mandatory)

Educate patients about: 1

• Natural history: 30-60% spontaneous recovery rate, most within first 2 weeks 1, 3
• Those recovering 50% of hearing in first 2 weeks have better prognosis 1
• Presence of vertigo indicates poorer prognosis 1
• Benefits and risks of medical interventions 1
• Limitations of existing evidence regarding treatment efficacy 1
• Potential side effects: hyperglycemia, hypertension, insomnia, weight gain, mood changes 1

Follow-Up Requirements

Obtain audiometric evaluation: 1

• At conclusion of treatment 1
• Within 6 months of treatment completion 1

For residual hearing loss and/or tinnitus: Counsel about audiologic rehabilitation, hearing aids, and other supportive measures. 1 This is a strong recommendation that should not be overlooked. 1

Common Pitfalls to Avoid

Time is critical - treatment efficacy decreases significantly after 2 weeks, though benefit has been reported up to 6 weeks. 1, 4 Do not delay treatment for extensive workup. 5

Contraindications to systemic steroids (insulin-dependent diabetes, labile hypertension, glaucoma, peptic ulcer disease, psychiatric reactions to steroids) should prompt intratympanic therapy, not observation. 1

Bilateral SSNHL or recurrent episodes require investigation for systemic disease (autoimmune conditions, syphilis, Lyme disease) and represent a different clinical entity. 1, 2

Watchful waiting is an option given spontaneous recovery rates of 30-60%, but most clinicians offer treatment given the low risk profile of short-course steroids and potential for improved outcomes. 1, 6